Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAD3-dtNzYNW9vNnC6elXpYrdlZi7quPelxB9a0MzH7uE#provenance>. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion wasAttributedTo 0000-0002-3668-2627 provenance.
- assertion generatedAtTime "2022-10-11T07:11:20.835226" provenance.
- assertion wasQuotedFrom " TNKase® (Tenecteplase) is indicated for use in the reduction of mortality associated with acute myocardial infarction (AMI) Treatment should be initiated as soon as possible after the onset of AMI symptoms, according to the drug's manufacturer. The drug is available in the US for $1,000 in the U.S. and Europe for $2,000." provenance.
- vocab version "2.3.0" provenance.